Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism.
| Image |  |
|---|---|
| Description | scientific article published on 24 May 2017 |
| Author/s |
author: Christoph Borzikowsky |
| Publication date | May 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |